[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338146-105":59,"doc-detail-338146-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-of-a-prognostic-model-for-nsclc-based-on-differential-genes-in-tumour-stem-cells","Development of a Prognostic Model for NSCLC based on Differential Genes in Tumour Stem Cells","","Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality, and cisplatin resistance limits effective first-line therapy and worsens prognosis. This work integrates NSCLC single-cell RNA-seq data from GEO and a Ku Leuven-related dataset with bulk RNA-seq data from TCGA. Differential genes in tumour stem cell populations are used to build and validate a machine-learning prognostic risk model, yielding an 8-gene signature supported by Cox-based selection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-of-a-prognostic-model-for-nsclc-based-on-differential-genes-in-tumour-stem-cells/338146/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-of-a-prognostic-model-for-nsclc-based-on-differential-genes-in-tumour-stem-cells/338146.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What datasets are used to build the NSCLC prognostic model?","Question",{"text":112,"@type":113},"Single-cell RNA-seq data are downloaded from the GEO database and a Ku Leuven Laboratory source, while bulk RNA-seq data are obtained from TCGA.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are differential genes and prognostic genes identified?",{"text":117,"@type":113},"Differentially expressed genes in tumour stem cells are identified using Seurat marker detection. Univariate regression analyses are then applied to the DEGs to identify potential prognostic genes.",{"name":119,"@type":110,"acceptedAnswer":120},"Which gene signature and model combination performs best?",{"text":121,"@type":113},"The final best-performing model is selected as 'StepCox[both] + RSF', comprising 8 genes, and it shows relatively high prediction accuracy across TCGA and GEO datasets.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338146,1790210454,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDevelopment of a prognostic model for NSCLC based on differential genes in tumour stem cells  \nYuqi Ma1,3, Jiawei Li1,3, Chunping Xiong2,3, Xiaoluo Sun1,3 & Tao Shen1*  \nNon-small cell lung cancer (NSCLC) constitutes a significant portion of lung cancers and cytotoxic drugs (e.g. cisplatin) are currently the first-line treatment. However, NSCLC has developed resistance to this drug, which limits the therapeutic effect and thus affects prognosis. NSCLC sc-RNA-seq data were downloaded from the GEO database and Ku Leuven Laboratory for Functional Epigenetics, and bulk RNA-seq data were obtained from theTCGA database. The“Seurat” package was employed for scRNA-seq data processing, and the uniform manifold approximation and projection (UMAP) were applied for downscaling and cluster identification. Use the FindAllMarkers function to find differential genes (DEGs) for tumor stem cells. Then, we performed univariate regression analyses on the DEGsto identify potential prognostic genes. We created a machine learning framework based on potential prognostic genes, which combines 10 machine learning methods and their 101 combinations to get the optimal prognostic risk model. The model was evaluated in the training set and validation set. A nomogram was developed to provide physicians with a quantitative tool for prognosis prediction. Finally, we evaluated the expression and functionality of SLC2A1. We discovered 22 cell clusters containing 218379 cells by examining single-cell RNA sequencing datasets (GSE148071, KU_lom, GSE131907, GSE136246, GSE127465). Tumour cells were isolated for subpopulation analysis and 162 differential genes from SOX2_cancer were obtained. After univariate Cox analysis, we found 23 genes with prognostic potential prognostic value and utilized them to develop 101-combination machine learning computational framework. We eventually picked the best performing ‘StepCox[both] + RSF’, which includes 8 genes. The model has a relatively high prediction accuracy in both TCGA and GEO datasets. In in vitro investigations, targeted suppression of the SLC2A1 gene resulted in significant reductions in proliferation, invasion and migration inA549 cells. In addition, a significant reduction in cisplatin resistance was seen inA549/DDP cells. The outcomes demonstrated the precision and credibility of the prognostic model for NSCLC, highlighting its potential significance in the treatment and prognosis of individuals affected by this disease. SLC2A1 may become a promising prognostic marker and a potential therapeutic target, offering valuable insights to inform clinical treatment decisions.  \nKeywords NSCLC, Single cell, Machine learning, Prognosis  \nAbbreviations  \nNSCLCscRNA-seq GEO  \nTCGA  \nOS  \nROC  \nDEGs  \nRFS  \nNon-small cell lung cancer NSCLC Single-cell RNA sequencing Gene expression omnibus The cancer genome atlas  \nOverall survival  \nReceiver operating characteristic Differentially expressed genes Random forest  \n1School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China. 2Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. 3These authors contributed equally: Yuqi  \nMa, Jiawei Li, Chunping Xiong and Xiaoluo Sun.* email: [st@cdutcm.edu.cn](st@cdutcm.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nAUC Area under the curve  \nGSEA Gene set enrichment analysis  \nLung cancer stands as the primary cause of worldwide cancer-related fatalities, accounting for over 1.8 million annual deaths attributed to lung cancer1. Approximately 80–85% of all lung cancers are attributed to NSCLC. Among individuals initially diagnosed with locally advanced or metastatic disease, nearly 70% will receive an NSCLC diagnosis2.  \nThe main strategy for managing NSCLC involves chemotherapy. Platinum-based medications are regarded asthe first-line standard, as endorsed by","cbCaimYjPb01pMSw","https://ap.wps.com/l/cbCaimYjPb01pMSw","pdf",8229330,12,"English","# Background\n## Chemotherapy and cisplatin resistance\n## Sequencing technologies and prior work\n# Methods\n## Data sources and preprocessing\n## Differential gene identification\n## Prognostic gene selection and model building\n## Nomogram construction\n# Results\n## Clustering and DEG discovery\n## Selected prognostic gene signature\n## Model performance in training/validation\n## Experimental validation of SLC2A1","[{\"question\":\"What datasets are used to build the NSCLC prognostic model?\",\"answer\":\"Single-cell RNA-seq data are downloaded from the GEO database and a Ku Leuven Laboratory source, while bulk RNA-seq data are obtained from TCGA.\"},{\"question\":\"How are differential genes and prognostic genes identified?\",\"answer\":\"Differentially expressed genes in tumour stem cells are identified using Seurat marker detection. Univariate regression analyses are then applied to the DEGs to identify potential prognostic genes.\"},{\"question\":\"Which gene signature and model combination performs best?\",\"answer\":\"The final best-performing model is selected as 'StepCox[both] + RSF', comprising 8 genes, and it shows relatively high prediction accuracy across TCGA and GEO datasets.\"}]","Development of a Prognostic Model for NSCLC based on Differential Genes in Tumour Stem Cells | PDF",1790022200,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/800f6883a6e5ffc6b46dbe245e3879b0.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8559a6fb00a80f27cc21cf1bc4bf957e.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd95052123f73895f9983c1bc65906ec.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a2df6815b99ba1abe43fe69411b010b.webp",980,1287]